Clinical Trial Update: Study of Ofatumumab and ESHAP for the Treatment of Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of ofatumumab with the ESHAP regimen for Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• ESHAP regimen
• Ofatumumab (ofatumumab)

Snippet

Sponsor: Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea | Conditions: Hodgkin Disease | Phase 2 | Status: COMPLETED